|
|||||
|
|
| Latest Insider Trading | Top Insider Trading Recent Week | Top 10% Owner Trading Recent Week | Filter
|
| Ticker | Owner | Relationship | Date | Transaction | Cost |
#Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| OLMA | Myles David C. | Officer | Dec 19 '25 | Proposed Sale | 30.46 | 51,000 | 1,553,447 | Dec 19 04:33 PM | |
| OLMA | Myles David C. | CH. DISCOV. & NON-CLIN DEV OFF | Dec 10 '24 | Sale | 9.38 | 12,452 | 116,800 | 611,947 | Dec 11 07:56 PM |
| OLMA | Myles David C. | CH. DISCOV. & NON-CLIN DEV OFF | Dec 11 '24 | Sale | 8.68 | 13,614 | 118,116 | 598,333 | Dec 11 07:56 PM |
| OLMA | Myles David C. | Officer | Dec 11 '24 | Proposed Sale | 8.68 | 13,614 | 118,180 | Dec 11 04:52 PM | |
| OLMA | Myles David C. | Officer | Dec 10 '24 | Proposed Sale | 9.38 | 12,452 | 116,748 | Dec 10 02:48 PM | |
| OLMA | Myles David C. | CH. DISCOV. & NON-CLIN DEV OFF | Nov 21 '23 | Sale | 14.88 | 6,976 | 103,823 | 580,752 | Nov 22 07:00 PM |
| OLMA | Myles David C. | CH. DISCOV. & NON-CLIN DEV OFF | Nov 22 '23 | Sale | 13.89 | 6,653 | 92,410 | 574,099 | Nov 22 07:00 PM |
| OLMA | Myles David C. | CH. DISCOV. & NON-CLIN DEV OFF | Nov 08 '23 | Sale | 17.61 | 200 | 3,522 | 561,270 | Nov 13 05:30 PM |
| OLMA | Myles David C. | CH. DISCOV. & NON-CLIN DEV OFF | Nov 01 '23 | Sale | 15.02 | 6,668 | 100,153 | 565,343 | Nov 03 09:39 PM |
| OLMA | Myles David C. | CH. DISCOV. & NON-CLIN DEV OFF | Nov 02 '23 | Sale | 15.36 | 3,332 | 51,180 | 562,011 | Nov 03 09:39 PM |
| OLMA | Myles David C. | CH. DISCOV. & NON-CLIN DEV OFF | Nov 03 '23 | Sale | 17.51 | 541 | 9,473 | 561,470 | Nov 03 09:39 PM |
| OLMA | Myles David C. | CH. DISCOV. & NON-CLIN DEV OFF | Sep 19 '23 | Sale | 12.67 | 20,000 | 253,400 | 572,011 | Sep 21 05:00 PM |
| OLMA | Myles David C. | CHIEF DEVELOPMENT OFFICER | Dec 10 '21 | Sale | 10.30 | 10,000 | 103,000 | 582,901 | Dec 14 04:03 PM |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite